Contact this trialFirst, we need to learn more about you.
RNA Disruption Assay for Breast Cancer
Recruiting1 award7 criteria
Saint Louis, Missouri
This trial tests a new method called RNA Disruption Assay to see if it can help doctors determine early on if breast cancer patients' tumors are responding to chemotherapy. By analyzing the tumor's RNA, the test aims to guide treatment decisions and improve patient outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service